Cargando…
Design and rationale of the inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure (CAVAL US-AHF Study): a randomised controlled trial
BACKGROUND: Between 25% and 30% of patients hospitalised for acute heart failure (AHF) are readmitted within 90 days after discharge, mostly due to persistent congestion on discharge. However, as the optimal evaluation of decongestion is not clearly defined, it is necessary to implement new tools to...
Autores principales: | Burgos, Lucrecia Maria, Baro Vila, Rocio, Goyeneche, Ailin, Muñoz, Florencia, Spaccavento, Ana, Fasan, Martin Andres, Ballari, Franco, Vivas, Martin, Riznyk, Laura, Ghibaudo, Sebastian, Trivi, Marcelo, Ronderos, Ricardo, Costabel, Juan Pablo, Botto, Fernando, Diez, Mirta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644364/ https://www.ncbi.nlm.nih.gov/pubmed/36344108 http://dx.doi.org/10.1136/openhrt-2022-002105 |
Ejemplares similares
-
What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015) -
Inferior vena cava diameter and risk of acute decompensated heart failure rehospitalisations
por: Sampath-Kumar, Revathy, et al.
Publicado: (2023) -
Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals
por: Cheang, Mun Hong, et al.
Publicado: (2015) -
Five-year outcomes following left ventricular assist device implantation in England
por: Bottle, Alex, et al.
Publicado: (2021) -
Changes in heart failure management and long-term mortality over 10 years: observational study
por: Bottle, Alex, et al.
Publicado: (2022)